DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20182910

Refractory hyperactive bladder treated with sacral neuromodulator: case report and literature review

Junior J. Araiza J. Araiza Navarro, Raúl D. Lara Sánchez, Oyuki A. Morales Uscanga, María I. Tolentino Sosa, Fernando López Reyes, Jorge A. Barbabosa Vilchis

Abstract


The overactive bladder syndrome is a chronic medical condition that affects the quality of life of patients whether men or women, has a prevalence of 16.5%, however, it is known to increase with age, affecting up to 25% of women older than 65 years and up to 80% in the elderly. More than 90% of cases have no apparent cause.  The OAB (Overactive Bladder) It is a condition with characteristic symptoms of urinary urgency, usually accompanied by frequency and nocturia, with or without urge incontinence, in the absence of urinary tract infection or other obvious pathology. The different therapeutic steps are not always sufficient to restore the quality of life.


Keywords


Detrusor overactivity, Sacral neuromodulator, Urinary incontinence, Urodynamics

Full Text:

PDF

References


de Boer TA, Slieker-ten Hove MCP, Burger CW, Vierhout ME. The prevalence and risk factors of overactive bladder symptoms and its relation to pelvic organ prolapse symptoms in a general female population. Int Urogynecol J. 2011;22(5):569-75.

Irwin DE, Milsom I, Hunskaar S, Reilly K, Kopp Z, Herschorn S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306

Vo A, Kielb SJ. Female voiding dysfunction and urinary incontinence. Med Clinics N Am. 2017 Dec 20. Available at: org/10.1016/j.mcna.2017.10.006

Musco S, PadillaFernández B, Del Popolo G, Bonifazi M, Blok BF, Groen J, et al. Value of urodynamic findings in predicting upper urinary tract damage in neuro-urological patients: A systematic review. Neurourol Urodynam. 2018;1-19. Available at: https://doi.org/10.1002/nau.23501.

Thuroff JW, Abrams P, Andersson KE, Artibani W, Chapple CR, Drake MJ, et al. EAU Guidelines on Urinary Incontinence. Actas Urol Esp. 2011;35:373-88.

Yamaguchi O, Nishizawa O, Takeda M, Yokoyama O, Homma Y, Kakizaki H, et al. Clinical guidelines for overactive bladder. Int J Urol. 2009;16:126-42.

Hashim H, Abrams P. How should patients with an overactive bladder manipulate their fluid intake?. BJU Int. 2008 Jul 1;102(1):62-6.

Lohsiriwat S, Hirunsai M, Chaiyaprasithi B. Effect of caffeine on bladder function in patients with overactive bladder symptoms. Urol Annals. 2011;3(1):14-8.

Shafik A, Shafik IA. Overactive bladder inhibition in response to pelvic floor muscle exercises. World J Urol. 2003 May 1;20(6):374-7.

Robinson D, Cardozo L. Antimuscarinic drugs to treat overactive bladder. BMJ. 2012 Mar 27;344:e2130. Available at: 10.1136/bmj.e2130

Schmid DM, Sauermann P, Werner M, Schuessler B, Blick N, Muentener M, et al. Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol. 2006;176:177-85.

Van Kerrebroeck PE, van Voskuilen AC, Heesakkers JP, Lycklama á Nijholt AA, Siegel S, Jonas U, et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: results of a prospective clinical study worldwide. J Urol. 2007;178:2029-34.

Somani BK, Kumar V, Wong S, Pickard R, Ramsay C, Nabi G, et al. Bowel dysfunction after transposition of intestinal segments into the urinary tract: 8-year prospective cohort. J Urol. 2007;177:1793-8.

Stewart W, Van Rooyen J, Cundiff G, Abrams P, Herzog A, Corey R, et al. Prevalence and burden of overactive bladder in the United States. World J Urol. 2003 May 1;20(6):327-36.

Middelkoop HA, Smilde-van den Doel DA, Neven AK, Kamphuisen HA, Springer CP. Characteristics of the subjective sleep of 1,485 men and women aged 50 to 93 years: effects of sex and age, and factors related to the self-rated quality of sleep. J Gerontol Biol Sci Med Sci. 1996;51:M108-15 PMID: 8630703.

Van der Vaart CH, Roovers JP, de Leeuw JR, Heintz AP. Association between urogenital symptoms and depression in community -dwelling women aged 20 to 70 years. Urol. 2007;69:691-6.

Abrams P. Nocturia: the effect on sleep and related health consequences. Europ Urol Supp. 2005 Jan 1;3(6):1-7.

de Groat WC. A neurologic basis for the overactive bladder. Urol. 1997;50(6A suppl):36-52. PMID 9426749.

Brading AF. Spontaneous activity of lower urinary tract smooth muscles: correlation between ion channels and tissue function. J Physiol. 2006;570:13-22.

Drake MJ, Mills IW, Gillespie JI. Model of peripheral autonomous modules and a myovesical plexus in normal and overactive bladder function. Lancet. 2001;358:401-3.

Andersson KE. Detrusor myocyte activity and afferent signaling. Neurourol Urodyn. 2010;29:97-106.

Howard B. Goldman, International Continence Society best practice statement for use of sacral neuromodulation, Neurourol Urodynam. 2018;1-26.